Abbvie Inc at Bank of America Global Healthcare Conference Transcript

May 09, 2023 / 03:00PM GMT
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst

Welcome to the BofA Healthcare Conference. My name is Geoff Meacham, I'm a senior biopharma analyst here at BofA. And we're happy to kick it off with AbbVie today.

So with me on stage, we have Rob Michael, Vice Chairman and President; Scott Reents, EVP, CFO; Jeff Stewart, EVP, CCO; and then Roopal Thakkar, who is SVP, Development, Regulatory Affairs and CMO. So guys, thanks for coming.

Robert A. Michael - AbbVie Inc. - Vice Chairman & President

Thanks for having us.

Questions and Answers:

Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst

Always a big crew, right? Rob, I'll kick it off to you. So when we talk about the cadence of this year, you guys have given pretty good specifics on the flow of earnings trough just with respect to the HUMIRA erosion. As you have moved through the year so far, what would you say is kind of better or worse than you thought initially? What are the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot